PMC:7417114 / 55853-56175
Annnotations
LitCovid-PD-FMA-UBERON
Id | Subject | Object | Predicate | Lexical cue | fma_id |
---|---|---|---|---|---|
T272 | 0-7 | Body_part | denotes | capsule | http://purl.org/sig/ont/fma/fma85272 |
T273 | 93-99 | Body_part | denotes | plasma | http://purl.org/sig/ont/fma/fma62970 |
T274 | 100-108 | Body_part | denotes | proteins | http://purl.org/sig/ont/fma/fma67257 |
T275 | 187-191 | Body_part | denotes | lung | http://purl.org/sig/ont/fma/fma7195 |
LitCovid-PD-UBERON
Id | Subject | Object | Predicate | Lexical cue | uberon_id |
---|---|---|---|---|---|
T83 | 0-7 | Body_part | denotes | capsule | http://purl.obolibrary.org/obo/UBERON_0003893 |
T84 | 187-191 | Body_part | denotes | lung | http://purl.obolibrary.org/obo/UBERON_0002048 |
LitCovid-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T532 | 192-204 | Disease | denotes | inflammation | http://purl.obolibrary.org/obo/MONDO_0021166 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T624 | 87-92 | http://purl.obolibrary.org/obo/NCBITaxon_9606 | denotes | human |
T625 | 93-99 | http://purl.obolibrary.org/obo/UBERON_0001969 | denotes | plasma |
T626 | 152-153 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T627 | 187-191 | http://purl.obolibrary.org/obo/UBERON_0002048 | denotes | lung |
T628 | 187-191 | http://www.ebi.ac.uk/efo/EFO_0000934 | denotes | lung |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T49 | 59-63 | Chemical | denotes | drug | http://purl.obolibrary.org/obo/CHEBI_23888 |
T43402 | 100-108 | Chemical | denotes | proteins | http://purl.obolibrary.org/obo/CHEBI_36080 |
T80590 | 208-219 | Chemical | denotes | palbociclib | http://purl.obolibrary.org/obo/CHEBI_85993 |
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
1581 | 87-92 | Species | denotes | human | Tax:9606 |
1582 | 228-236 | Species | denotes | patients | Tax:9606 |
LitCovid-PD-GO-BP
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T167 | 192-204 | http://purl.obolibrary.org/obo/GO_0006954 | denotes | inflammation |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T463 | 76-237 | Sentence | denotes | binding to human plasma proteins accounts=85% of administered dose There is a small risk of potentially severe lung inflammation in palbociclib-treated patients. |
T464 | 238-274 | Sentence | denotes | Abemaciclib (Verzenio and Verzenios) |
LitCovid-PMC-OGER-BB
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T2209 | 0-322 | SP_7 | denotes | capsule orally once daily for 21 days followed by one week drug abstinence; binding to human plasma proteins accounts=85% of administered dose There is a small risk of potentially severe lung inflammation in palbociclib-treated patients. Abemaciclib (Verzenio and Verzenios) (Eli Lilly) Following oral dose 200 mg,Cmax=158 |